LIA
PVCT
LBMC Investment Advisors’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.5K | Hold |
20,000
| – | – | ﹤0.01% | 212 |
|
|
2025
Q1 | $2K | Hold |
20,000
| – | – | ﹤0.01% | 199 |
|
|
2024
Q4 | $2.4K | Hold |
20,000
| – | – | ﹤0.01% | 196 |
|
|
2024
Q3 | $1.96K | Sell |
20,000
-2,000
| -9% | -$196 | ﹤0.01% | 193 |
|
|
2024
Q2 | $2.77K | Hold |
22,000
| – | – | ﹤0.01% | 185 |
|
|
2024
Q1 | $4.02K | Hold |
22,000
| – | – | ﹤0.01% | 184 |
|
|
2023
Q4 | $2.11K | Hold |
22,000
| – | – | ﹤0.01% | 164 |
|
|
2023
Q3 | $1.72K | Hold |
22,000
| – | – | ﹤0.01% | 160 |
|
|
2023
Q2 | $2.49K | Hold |
22,000
| – | – | ﹤0.01% | 164 |
|
|
2023
Q1 | $3.63K | Hold |
22,000
| – | – | ﹤0.01% | 162 |
|
|
2022
Q4 | $2.38K | Hold |
22,000
| – | – | ﹤0.01% | 157 |
|
|
2022
Q3 | $1K | Buy |
+22,000
| New | +$1K | ﹤0.01% | 151 |
|
|
2021
Q4 | – | Sell |
-22,000
| Closed | -$1 | – | 171 |
|
|
2021
Q3 | $1 | Buy |
+22,000
| New | +$1 | ﹤0.01% | 162 |
|
|
2019
Q2 | – | Sell |
-22,000
| Closed | -$1K | – | 102 |
|
|
2019
Q1 | $1K | Buy |
+22,000
| New | +$1K | ﹤0.01% | 99 |
|